Extending Biosafety Testing to Gene Therapy Products
To overcome the biosafety challenges posed by viral vectors, biomanufacturers are applying Bac-to-AAV, 2D-HPLC, QbD, LC-MS/MS, and other technologies.
Shengjiang Shawn Liu Xiaotong Fu Nasir Bashiruddin Andrew Hanneman Bioprocess International Conference Bioprocess Summit
Source: genengnews.com